Ubs Group Ag Moderna, Inc. Call Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $13.2 Million - $26 Million	207,858 Added 127.36%	371,058 $24.8 Million
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $5.35 Million - $8.81 Million	-52,900 Reduced 24.48%	163,200 $19.4 Million
Q1 2024 May 13, 2024	SELL	$85.37 - $115.44 $28.2 Million - $38.2 Million	-330,600 Reduced 60.47%	216,100 $23 Million
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $10.5 Million - $15.8 Million	151,000 Added 38.16%	546,700 $54.4 Million
Q3 2023 Nov 09, 2023	BUY	$96.41 - $126.61 $14.9 Million - $19.6 Million	155,000 Added 64.4%	395,700 $40.9 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $13.3 Million - $18.1 Million	-112,636 Reduced 31.88%	240,700 $29.2 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $19.9 Million - $28.9 Million	146,700 Added 70.99%	353,336 $54.3 Million
Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $16.1 Million - $28.6 Million	136,153 Added 193.17%	206,636 $37.1 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $4.78 Million - $7.86 Million	40,483 Added 134.94%	70,483 $8.34 Million
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $3.26 Million - $4.91 Million	-27,800 Reduced 48.1%	30,000 $4.29 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $5.79 Million - $10.8 Million	45,800 Added 381.67%	57,800 $9.96 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $451,640 - $737,020	2,000 Added 20.0%	12,000 $3.05 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $643,510 - $1.4 Million	-2,900 Reduced 22.48%	10,000 $3.85 Million
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $512,771 - $1.32 Million	-7,800 Reduced 37.68%	12,900 $1.35 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $364,078 - $635,495	6,700 Added 47.86%	20,700 $1.47 Million
Q1 2020 May 01, 2020	BUY	$17.78 - $31.58 $248,920 - $442,120	14,000 New	14,000 $419,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account